Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months

por Inoue K, Okayama R, Higa R, Tomita G
Publicado 2014

Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination

por Inoue K, Okayama R, Higa R, Wakakura M, Tomita G
Publicado 2012

Switching from concomitant therapy to tafluprost/timolol fixed combination

por Inoue K, Kawashima T, Katakura S, Shidara K, Fujimoto T, Kohmoto H, Shiokawa M, Moriyama R, Okayama R
Publicado 2018